Our Advisory Board
Tasked with guiding the evolution of ScienceMedia's product development portfolio, these luminaries play a pivotal role in identifying industry gaps and shaping strategic initiatives to drive business growth. ScienceMedia's Advisory Board has a profound understanding of experience across clinical trial operations at the sponsor, CRO, and site levels, as well as in production innovation, rare diseases, and patient advocacy.
Jocelyn M. Ashford
Head of US Corporate Affairs, CVRM, AstraZeneca
Jocelyn M. Ashford is a Corporate Affairs and Patient Advocacy executive with over 20 years of pharmaceutical and biotech experience. She is a keynote speaker and industry expert known for uncovering insights and transforming them into high-impact solutions. Jocelyn holds a Master's degree in Engineering Management and a Bachelors degree in Industrial Engineering & Economics from Northwestern University in Evanston, IL.
Dawn Sauro
Board Advisor,
ScienceMedia, Inc.
Over 30 years of drug and device development experience. Currently Dawn is consulting and supporting clinical research organizations and investors with operational and commercial insights. Prior to that she served as the Chief Growth Officer at WCG Clinical, responsible for the company's enterprise growth and commercialization strategy. P rior to WCG, was Elligo Health Research's COO where she furthered company's growth, efficiency and mission of optimizing the intersection of healthcare and research. Dawn was also the Chief Development Officer at Clinipace (now Caidya) where she developed the strategy and grew the organization to be a trusted partner for sponsors. Prior roles included President, Development Innovations at Sarah Cannon and SVP and General Manager Hematology/Oncology at inVentiv Health (now Syneos).
Elle Hamilton
Chief Executive Officer,
REVIOS Strategies
Elle's leadership spans business development, marketing, and communications in the biopharmaceutical world. A former VP of client partnerships and business development at leading CRO and commercial services organization Syneos Health, she has spearheaded initiatives across patient diversity and engagement, clinical trial recruitment, launch strategy, R&D communications, and strategic partnerships. Her clients have included many of the largest pharmaceutical companies, as well as small biotechs and startups. She is an AI enthusiast and active leader in the Healthcare Businesswomen�s Association.
Elaine Gamble
Board Advisor,
ScienceMedia, Inc.
Elaine Gamble is a recognized digital and omnichannel executive and strategic advisor with more than two decades of commercial leadership across the biopharmaceutical and healthcare sectors. As Managing
Partner at EGA Partners LLC, she advises life sciences enterprises on enterprise-scale omnichannel customer experience, modern data architectures, and practical artificial intelligence integration
designed to elevate commercial execution and improve patient outcomes. Her corporate background includes serving as Head of Omnichannel Engagement for the Neuroscience Division at Otsuka America Pharmaceuticals, as well as commercial leadership roles at Merck and Novartis. Throughout her career, Elaine has specialized in driving marketing transformation and establishing Centers of Excellence that harmonize field-force interactions with intelligent digital ecosystems through rigorous strategy, advanced analytics, and scalable operating models.
A prominent voice in modern commercial strategy and governance, Elaine has served on the 2026 American Marketing Association's Future of Marketing Expert Panel as one of 30 global leaders shaping the discipline's
forward horizon. Her cross-industry experience includes co-chairing the Relationship Marketing Committee for the Association of National Advertisers (ANA), serving as an advisory board member at Google Health Marketing and Advertising, and serving as a final-round judge for the Effie Awards. Complementing her commercial background, Elaine also brings proven governance experience through her service on the Board of Directors for the New York Classical Theatre.
Elaine holds a Bachelor of Arts from Oberlin College and a Master of Business Administration from the Kellogg School of Management at Northwestern University. She is based in New York City.
Carrie Melvin
Senior Vice President, Global Clinical Operations & Medical Writing, Stemline Therapeutics
Carrie Melvin is currently the SVP of Clinical Operations and Medical Writing at Stemline Therapeutics. Prior to Stemline, she was the COO at Viridian Therapeutics. Carrie has been in the pharmaceutical/biotech industry for well over 20 years, beginning her career at Pfizer as a Clinical Study Associate. She has taken on roles with increased responsibilities at various companies throughout her career. When not working, Carrie enjoys spending time with friends and family.
Janet White
Portfolio & Platform Lead, Global Health Programs,
Bill & Melinda Gates Foundation
Janet White is a Portfolio & Platform Lead in the Global Health Program at the Bill & Melinda Gates Foundation, where she leverages her scientific and technical product development expertise to make and manage investments up to $100 million in North American, European, and Asian biopharmaceutical companies to bring affordable drugs and vaccines to developing countries.
Shaun Urban
Board Advisor, ScienceMedia, Inc.
Shaun is a 28-year executive and commercial leader within the Life Sciences industry, with diverse experience spanning advertising, marketing communications, market access, medical communications, business development, events, production, and tech-enabled services. He currently provides strategic and commercial consulting services to private equity firms and pharma services businesses, including due diligence, go-to-market strategies, organizational design, and partnership development. Shaun previously led The Inception Company through a period of exponential growth, culminating in its sale to a private equity sponsor. He has received industry awards and served on nonprofit boards, including the American Heart Association. Shaun holds a Bachelor of Science degree in Pharmacy from Purdue University.
Our Advisory Board
Tasked with guiding the evolution of ScienceMedia�s product development portfolio, these luminaries play a pivotal role in identifying industry gaps and shaping strategic initiatives to drive business growth. ScienceMedia�s Advisory Board has a profound understanding of experience across clinical trial operations at the sponsor, CRO, and site levels, as well as in production innovation, rare diseases, and patient advocacy.
Jocelyn M. Ashford
Head of US Corporate Affairs,
CVRM, AstraZeneca
Jocelyn M. Ashford is a Corporate Affairs and Patient Advocacy executive with over 20 years of pharmaceutical and biotech experience. She is a keynote speaker and industry expert known for uncovering insights and transforming them into high-impact solutions. Jocelyn holds a Master�s degree in Engineering Management and a Bachelors degree in Industrial Engineering & Economics from Northwestern University in Evanston, IL.
Dawn Fury
Senior Vice President,
Enterprise Delivery
Operations, Signant Health
Through 25 years of clinical operations experience stemming from her time at Merck & Co., Dawn developed a love for Lean Six Sigma process improvement and a �One Team� approach to clinical trial operations. During her tenure at Janssen, she is proud to have helped bring multiple life-saving drugs to patients and participated in Operation Warp Speed in 2020 as the Operational Liaison for the development of the J&J COVID-19 vaccine.
Elle Hamilton
Chief Executive Officer,
REVIOS Strategies
Elle�s leadership spans business development, marketing, and communications in the biopharmaceutical world. A former VP of client partnerships and business development at leading CRO and commercial services organization Syneos Health, she has spearheaded initiatives across patient diversity and engagement, clinical trial recruitment, launch strategy, R&D communications, and strategic partnerships. Her clients have included many of the largest pharmaceutical companies, as well as small biotechs and startups. She is an AI enthusiast and active leader in the Healthcare Businesswomen�s Association.
Melissa Holbrook
Principal Clinical Consultant/
Research Site Advisor
Melissa Holbrook, MSN, NP, is a seasoned healthcare professional with over two decades of clinical research experience and executive leadership roles. As Head of Operations, she streamlined processes, enhanced efficiency, and elevated patient care quality. Melissa�s diverse career spans academic institutions and cutting-edge research facilities, contributing to groundbreaking medical discoveries. Her strategic vision and leadership skills bridge clinical practice and research, positioning her as a thought leader in healthcare. Melissa holds a Master of Science in Nursing degree from Duke University.
Carrie Melvin
Senior Vice President, Global
Clinical Operations & Medical
Writing, Stemline Therapeutics
Carrie Melvin is currently the SVP of Clinical Operations and Medical Writing at Stemline Therapeutics. Prior to Stemline, she was the COO at Viridian Therapeutics. Carrie has been in the pharmaceutical/biotech industry for well over 20 years, beginning her career at Pfizer as a Clinical Study Associate. She has taken on roles with increased responsibilities at various companies throughout her career. When not working, Carrie enjoys spending time with friends and family.
Janet White
Portfolio & Platform Lead,
Global Health Programs,
Bill & Melinda Gates Foundation
Janet White is a Portfolio & Platform Lead in the Global Health Program at the Bill & Melinda Gates Foundation, where she leverages her scientific and technical product development expertise to make and manage investments up to $100 million in North American, European, and Asian biopharmaceutical companies to bring affordable drugs and vaccines to developing countries.
Shaun Urban
Board Advisor, ScienceMedia, Inc.
Shaun is a 28-year executive and commercial leader within the Life Sciences industry, with diverse experience spanning advertising, marketing communications, market access, medical communications, business development, events, production, and tech-enabled services. He currently provides strategic and commercial consulting services to private equity firms and pharma services businesses, including due diligence, go-to-market strategies, organizational design, and partnership development. Shaun previously led The Inception Company through a period of exponential growth, culminating in its sale to a private equity sponsor. He has received industry awards and served on nonprofit boards, including the American Heart Association. Shaun holds a Bachelor of Science degree in Pharmacy from Purdue University.